La maladie de Parkinson en France (serveur d'exploration) - Checkpoint (PubMed)

Index « ISSN » - entrée « 0362-5664 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
0361-9230 < 0362-5664 < 0364-3190  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 33.
[0-20] [0 - 20][0 - 33][20-32][20-40]
Ident.Authors (with country if any)Title
001381 (1997) E. Courty [France] ; F. Durif ; M. Zenut ; P. Courty ; J. LavarennePsychiatric and sexual disorders induced by apomorphine in Parkinson's disease.
001429 (1996) O. Rascol [France] ; A J Lees ; J M Senard ; Z. Pirtosek ; J L Montastruc ; D. FuellRopinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease.
001443 (1996) R. Bordet [France] ; F. Broly ; A. Destée ; C. Libersa ; J J LafitteLack of relation between genetic polymorphism of cytochrome P-450IID6 and sporadic idiopathic Parkinson's disease.
001467 (1996) M E Llau [France] ; G. Durrieu ; M A Tran ; J M Senard ; O. Rascol ; J L MontastrucA study of dopaminergic sensitivity in Parkinson's disease: comparison in "de novo" and levodopa-treated patients.
001505 (1995) P. Limousin [France] ; P. Pollak ; J P Pfefen ; C L Tournier-Gervason ; R. Dubuis ; J E PerretAcute administration of levodopa-benserazide and tolcapone, a COMT inhibitor, Parkinson's disease.
001533 (1994) H. Bagheri [France] ; M. Berlan ; J M Senard ; O. Rascol ; J L MontastrucLacrimation in Parkinson's disease.
001537 (1994) R. Bordet [France] ; F. Broly ; A. Destee ; C. LibersaGenetic polymorphism of cytochrome P450 2D6 in idiopathic Parkinson disease and diffuse Lewy body disease.
001549 (1994) F. Tison [France] ; N. Fouillet ; P. HenryApomorphine increases blood glucose concentrations in Parkinson's disease.
001550 (1994) F. Durif [France] ; D. Deffond ; G. Dordain ; M. TournilhacApomorphine and diphasic dyskinesia.
001568 (1993) C L Gervason [France] ; P R Pollak ; P. Limousin ; J E PerretReproducibility of motor effects induced by successive subcutaneous apomorphine injections in Parkinson's disease.
001570 (1993) F. Durif [France] ; M. Paire ; D. Deffond ; A. Eschalier ; G. Dordain ; M. Tournilhac ; J. LavarenneRelation between clinical efficacy and pharmacokinetic parameters after sublingual apomorphine in Parkinson's disease.
001587 (1993) J M Senard [France] ; O. Rascol ; G. Durrieu ; M A Tran ; M. Berlan ; A. Rascol ; J L MontastrucEffects of yohimbine on plasma catecholamine levels in orthostatic hypotension related to Parkinson disease or multiple system atrophy.
001627 (1992) A P Feve [France] ; N. Bathien ; P. RondotChronic administration of L-dopa affects the movement-related cortical potentials of patients with Parkinson's disease.
001635 (1991) J L Montastruc [France] ; O. Rascol ; J M Senard ; V. Gualano ; H. Bagheri ; G. Houin ; A. Lees ; A. RascolSublingual apomorphine in Parkinson's disease: a clinical and pharmacokinetic study.
001648 (1991) G. Durrieu [France] ; J M Senard ; M A Tran ; A. Rascol ; J L MontastrucEffects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians.
001669 (1990) U. Sabatini [France] ; O. Rascol ; A. Rascol ; J L MontastrucMigraine attacks induced by subcutaneous apomorphine in two migrainous parkinsonian patients.
001679 (1990) O. Rascol [France] ; N. Fabre ; H. Ter V Inen ; Werner Poewe [Autriche] ; C. Lücking ; U. Rinne ; E. Dupont ; D. Hirt ; M. Hoyer ; X. LatasteCQA 206-291: a novel dopamine agonist in the treatment of Parkinson's disease.
001681 (1990) G. Durrieu [France] ; Y. Rispail ; E. Chatelut ; M. Berlan ; A. Rascol ; J L Montastruc ; P. MontastrucBeta-adrenergic sensitivity in Parkinson's disease: effect of levodopa treatment.
001696 (1989) H. Allain [France] ; D. Bentue-Ferrer ; D. Milon ; P. Moran ; F. Jacquemard ; G. DefawePregnancy and parkinsonism. A case report without problem.
001706 (1989) M. Berlan [France] ; O. Rascol ; J. Belin ; J P Moatti ; A. Rascol ; J L MontastrucAlpha 2-adrenergic sensitivity in Parkinson's disease.
001715 (1988) D. Bentué-Ferrer [France] ; H. Allain ; J M Reymann ; O. Sabouraud ; J. Van Den DriesscheLack of pharmacokinetic influence on levodopa by bromocriptine.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/ISSN.i -k "0362-5664" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/ISSN.i  \
                -Sk "0362-5664" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    ISSN.i
   |clé=    0362-5664
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024